Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adavosertib CNS Penetration in Recurrent GBM
NCT02207010Phase 1Completed
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Jul 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of adavosertib in glioblastoma (GBM), sponsored by St. Joseph's Hospital and Medical Center. Primary endpoints: Plasma concentration of AZD1775 and Intratumoral concentration of AZD1775. Started Jul 2014; status: completed.
02
Drugs
adavosertib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02207010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207010.